MPINet: Metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Li, Feng ^a   Xu, Yanjun ^a   Shang, Desi ^a   Yang, Haixiu ^a   Liu, Wei ^a,b   Han, Junwei ^a   Sun, Zeguo ^a   Yao, Qianlan ^a   Zhang, Chunlong ^a   Ma, Jiquan ^a,c   Su, Fei ^a   Feng, Li ^a   Shi, Xinrui ^a   Zhang, Yunpeng ^a   Li, Jing ^a   Gu, Qi ^a   Li, Xia ^a   Li, Chunquan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG INSTITUTE OF TECHNOLOGY   (China)

^c HEILONGJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID METABOLISM; ARTICLE; DRUG SENSITIVITY; GLOBAL METABOLITE NETWORK STRUCTURE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; METABOLITE; METABOLITE PATHWAY IDENTIFICATION; METABOLOMICS; METASTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PROSTATE CANCER; TRYPTOPHAN METABOLISM; ALGORITHM; BIOLOGY; COMPUTER PROGRAM; DIABETES MELLITUS, TYPE 2; DRUG SCREENING; GENE EXPRESSION REGULATION; MALE; METABOLISM; METABOLOME; PROCEDURES; PROSTATE TUMOR; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 2; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METABOLOME; METABOLOMICS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; SOFTWARE;

EID: 84904113579     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/325697     Document Type: Article

References (56)

1. Hollywood K., Brison D. R., Goodacre R., Metabolomics: current technologies and future trends. Proteomics 2006 6 17 4716 4723 2-s2.0-33748603444 10.1002/pmic.200600106 (Pubitemid 44375842)
2. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K. F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M., From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Research 2006 34 D354 D357 2-s2.0-33644874819
3. Joshi-Tope G., Gillespie M., Vastrik I., D'Eustachio P., Schmidt E., de Bono B., Jassal B., Gopinath G. R., Wu G. R., Matthews L., Lewis S., Birney E., Stein L., Reactome: a knowledgebase of biological pathways. Nucleic Acids Research 2005 33 D428 D432 2-s2.0-13444259844 10.1093/nar/gki072 (Pubitemid 40207909)
4. Li C., Li X., Miao Y., Wang Q., Jiang W., Xu C., Li J., Han J., Zhang F., Gong B., Xu L., SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Research 2009 37 19, article e131 2-s2.0-71049148804 10.1093/nar/gkp667
5. Fang Z., Tian W., Ji H., A network-based gene-weighting approach for pathway analysis. Cell Research 2012 22 565 580 10.1038/cr.2011.149
6. Chagoyen M., Pazos F., Tools for the functional interpretation of metabolomic experiments. Briefings in Bioinformatics 2013 14 6 737 744. 10.1093/bib/bbs055
7. Chagoyen M., Pazos F., MBRole: Enrichment analysis of metabolomic data. Bioinformatics 2011 27 5 730 731 2-s2.0-79951999565 10.1093/bioinformatics/ btr001 btr001
8. Kankainen M., Gopalacharyulu P., Holm L., Orešič M., MPEA-metabolite pathway enrichment analysis. Bioinformatics 2011 27 13 1878 1879 2-s2.0-79959441218 10.1093/bioinformatics/btr278 btr278
9. Xia J., Wishart D. S., MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Research 2010 38 2 W71 W77 2-s2.0-77954256613 10.1093/nar/gkq329 gkq329
10. Xia J., Wishart D. S., MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 2010 26 18 2342 2344 2-s2.0-77956550520 10.1093/bioinformatics/btq418 btq418
11. Pham L., Christadore L., Schaus S., Kolaczyk E. D., Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proceedings of the National Academy of Sciences of the United States of America 2011 108 32 13347 13352 2-s2.0-80051978793 10.1073/pnas.1100891108
12. Li Y., Agarwal P., Rajagopalan D., A global pathway crosstalk network. Bioinformatics 2008 24 12 1442 1447 2-s2.0-45449101889 10.1093/bioinformatics/ btn200 (Pubitemid 351850998)
13. Heinonen M., Shen H., Zamboni N., Rousu J., Metabolite identification and molecular fingerprint prediction through machine learning. Bioinformatics 2012 28 18 2333 2341 2-s2.0-84866437252 10.1093/bioinformatics/bts437 bts437
14. Werner E., Heilier J.-F., Ducruix C., Ezan E., Junot C., Tabet J.-C., Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2008 871 2 143 163 2-s2.0-48749115768 10.1016/j.jchromb.2008.07.004
15. KT W., Biased sampling: the non-central hypegeometric probability distribution [Ph.D. thesis] 1963 Stanford University
16. Sreekumar A., Poisson L. M., Rajendiran T. M., Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009 457 910 914 10.1038/nature07762
17. Wishart D. S., Tzur D., Knox C., Eisner R., Guo A. C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M.-A., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D. D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G. E., MacInnis G. D., Weljie A. M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B. D., Vogel H. J., Querengesser L., HMDB: the human metabolome database. Nucleic Acids Research 2007 35 1 D521 D526 2-s2.0-33846088138 10.1093/nar/gkl923 (Pubitemid 46056263)
18. Suhre K., Meisinger C., Döring A., Altmaier E., Belcredi P., Gieger C., Chang D., Milburn M. V., Gall W. E., Weinberger K. M., Mewes H.-W., Angelis M. H., Wichmann H.-E., Kronenberg F., Adamski J., Illig T., Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010 5 11 2-s2.0-78649735772 10.1371/journal.pone.0013953 e13953
19. Weinstein J. N., Kohn K. W., Grever M. R., Viswanadhan V. N., Rubinstein L. V., Monks A. P., Scudiero D. A., Welch L., Koursoukos A. D., Chiausa A. J., Paull K. D., Neural computing in cancer drug development: predicting mechanism of action. Science 1992 258 5081 447 451 2-s2.0-0026498426
20. Reinhold W. C., Sunshine M., Liu H., Varma S., Kohn K. W., Morris J., Doroshow J., Pommier Y., CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Research 2012 72 14 3499 3511 2-s2.0-84863910171 10.1158/0008-5472.CAN-12-1370
21. Kamburov A., Stelzl U., Lehrach H., Herwig R., The ConsensusPathDB interaction database: 2013 Update. Nucleic Acids Research 2013 41 1 D793 D800 2-s2.0-84876008750 10.1093/nar/gks1055
22. Kuhn M., Szklarczyk D., Franceschini A., von Mering C., Jensen L. J., Bork P., STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Research 2012 40 1 D876 D880 2-s2.0-84861508376 10.1093/nar/gkr1011
23. Frolkis A., Knox C., Lim E., Jewison T., Law V., Hau D. D., Liu P., Gautam B., Ly S., Guo A. C., Xia J., Liang Y., Shrivastava S., Wishart D. S., SMPDB: The small molecule pathway database. Nucleic Acids Research 2009 38 1 D480 D487 2-s2.0-75549091977 10.1093/nar/gkp1002 gkp1002
24. Campbell C., Thakar J., Albert R., Network analysis reveals cross-links of the immune pathways activated by bacteria and allergen. Physical Review E 2011 84 031929 10.1103/PhysRevE.84.031929
25. Wood S. N., Generalized Additive Models: An Introduction With R 2006 New York, NY, USA Chapman & Hall/CRC
26. Uyttenhove C., Pilotte L., Théate I., Stroobant V., Colau D., Parmentier N., Boon T., Van den Eynde B. J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Medicine 2003 9 10 1269 1274 2-s2.0-0142137237 10.1038/nm934 (Pubitemid 37279849)
27. Opitz C. A., Litzenburger U. M., Sahm F., Ott M., Tritschler I., Trump S., Schumacher T., Jestaedt L., Schrenk D., Weller M., Jugold M., Guillemin G. J., Miller C. L., Lutz C., Radlwimmer B., Lehmann I., Von Deimling A., Wick W., Platten M., An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011 478 7368 197 203 2-s2.0-80054041992 10.1038/nature10491
28. Siddiqui E. J., Thompson C. S., Mikhailidis D. P., Mumtaz F. H., The role of serotonin in tumour growth (Review). Oncology Reports 2005 14 6 1593 1597 2-s2.0-33644689195
29. Nie D., Che M., Grignon D., Tang K., Honn K. V., Role of eicosanoids in prostate cancer progression. Cancer and Metastasis Reviews 2001 20 3-4 195 206 2-s2.0-0035740016 10.1023/A:1015579209850 (Pubitemid 34595268)
30. Angelucci A., Garofalo S., Speca S., Bovadilla A., Gravina G. L., Muzi P., Vicentini C., Bologna M., Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells. Endocrine-Related Cancer 2008 15 1 91 100 2-s2.0-41349117825 10.1677/ERC-07-0100 (Pubitemid 351449730)
31. Hughes-Fulford M., Li C. F., Boonyaratanakornkit J., Sayyah S., Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Research 2006 66 3 1427 1433 2-s2.0-32944477374 10.1158/0008-5472.CAN-05-0914 (Pubitemid 43259923)
32. Ghosh J., Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochemical and Biophysical Research Communications 2004 315 3 624 635 2-s2.0-1242295294 10.1016/j.bbrc.2004.01.100 (Pubitemid 38229390)
33. Yang P., Cartwright C. A., Li J., Wen S., Prokhorova I. N., Shureiqi I., Troncoso P., Navone N. M., Newman R. A., Kim J., Arachidonic acid metabolism in human prostate cancer. International Journal of Oncology 2012 41 4 1495 1503 2-s2.0-84866524565 10.3892/ijo.2012.1588
34. Eisenhofer G., Kopin I. J., Goldstein D. S., Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacological Reviews 2004 56 3 331 349 2-s2.0-4143144205 10.1124/pr.56.3.1 (Pubitemid 39096594)
35. Thysell E., Surowiec I., Hörnberg E., Crnalic S., Widmark A., Johansson A. I., Stattin P., Bergh A., Moritz T., Antti H., Wikström P., Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS ONE 2010 5 12 2-s2.0-78649944454 10.1371/journal.pone.0014175 e14175
36. Fowler J. S., Logan J., Wang G.-J., Volkow N. D., Telang F., Zhu W., Franceschi D., Shea C., Garza V., Xu Y., Ding Y.-S., Alexoff D., Warner D., Netusil N., Carter P., Jayne M., King P., Vaska P., Comparison of monoamine oxidase A in peripheral organs in nonsmokers and smokers. Journal of Nuclear Medicine 2005 46 9 1414 1420 2-s2.0-27744571884 (Pubitemid 46173251)
37. Eisenhofer G., Huynh T. T., Hiroi M., Pacak K., Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma. Reviews in Endocrine and Metabolic Disorders 2001 2 3 297 311 2-s2.0-0035431823 10.1023/A:1011572617314 (Pubitemid 33640579)
38. Lind D. S., Arginine and cancer. Journal of Nutrition 2004 134, 2837S 2853S
39. Bronte V., Zanovello P., Regulation of immune responses by L-arginine metabolism. Nature Reviews Immunology 2005 5 8 641 654 2-s2.0-23444456772 10.1038/nri1668 (Pubitemid 41113195)
40. Raz I., Eldor R., Cernea S., Shafrir E., Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes/Metabolism Research and Reviews 2005 21 1 3 14 2-s2.0-12744279669 10.1002/dmrr.493
41. Savage D. B., Petersen K. F., Shulman G. I., Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiological Reviews 2007 87 507 520 10.1152/physrev.00024.2006 (Pubitemid 47084679)
42. Betteridge D. J., Lipid control in patients with diabetes mellitus. Nature Reviews Cardiology 2011 8 278 290 10.1038/nrcardio.2011.23
43. Staels B., Fonseca V. A., Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 2009 32 supplement 2 S237 S245 2-s2.0-75549086552
44. Kobayashi M., Ikegami H., Fujisawa T., Nojima K., Kawabata Y., Noso S., Babaya N., Itoi-Babaya M., Yamaji K., Hiromine Y., Shibata M., Ogihara T., Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 2007 56 1 239 247 2-s2.0-33847057732 10.2337/db06-0353
45. Nettleton J. A., Katz R., n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. Journal of the American Dietetic Association 2005 105 3 428 440 2-s2.0-14744280322 10.1016/j.jada.2004.11.029 (Pubitemid 40326734)
46. Avogaro A., Crepaldi C., Miola M., Maran A., Pengo V., Tiengo A., del Prato S., High blood ketone body concentration in Type 2 non-insulin dependent diabetic patients. Journal of Endocrinological Investigation 1996 19 2 99 105 2-s2.0-0029869875 (Pubitemid 26107179)
47. Handelsman Y., Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 2011 34 supplement 2 S244 S250 2-s2.0-79959785811 10.2337/dc11-s237
48. Krishna Mohan I., Das U. N., Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 2001 17 2 126 151 2-s2.0-0035113112 10.1016/S0899-9007(00)00468-8 (Pubitemid 32178289)
49. Kimura K., Nakamura Y., Inaba Y., Matsumoto M., Kido Y., Asahara S., Matsuda T., Watanabe H., Maeda A., Inagaki F., Mukai C., Takeda K., Akira S., Ota T., Nakabayashi H., Kaneko S., Kasuga M., Inoue H., Histidine augments the suppression of hepatic glucose production by central insulin action. Diabetes 2013 62 2266 2277 10.2337/db12-1701
50. Melnik B. C., Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World Journal of Diabetes 2012 3 38 53 10.4239/wjd.v3.i3. 38
51. Krebs M., Roden M., Nutrient-induced insulin resistance in human skeletal muscle. Current Medicinal Chemistry 2004 11 7 901 908 2-s2.0-1842534924 10.2174/0929867043455620 (Pubitemid 38425922)
52. Kozubik A., Vaculova A., Soucek K., Vondracek J., Turanek J., Hofmanova J., Novel anticancer platinum(IV) complexes with adamantylamine: their efficiency and innovative chemotherapy strategies modifying lipid metabolism. Metal-Based Drugs 2008 2008 15 417897 10.1155/2008/417897 (Pubitemid 351697081)
53. Hendrich A. B., Michalak K., Lipids as a target for drugs modulating multidrug resistance of cancer cells. Current Drug Targets 2003 4 1 23 30 2-s2.0-0037244775 10.2174/1389450033347172 (Pubitemid 36131638)
54. Huang D. W., Sherman B. T., Lempicki R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009 37 1 1 13 2-s2.0-58549112996 10.1093/nar/gkn923
55. Li C., Han J., Yao Q., Zou C., Xu Y., Zhang C., Shang D., Zhou L., Zou C., Sun Z., Li J., Zhang Y., Yang H., Gao X., Li X., Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Research 2013 41 9, article e101 2-s2.0-84877251556 10.1093/nar/gkt161
56. Liu W., Li C., Xu Y., Yang H., Yao Q., Han J., Shang D., Zhang C., Su F., Li X., Li X., Xiao Y., Zhang F., Dai M., Topologically inferring risk-active pathways toward precise cancer classification by directed random walk. Bioinformatics 2013 29 17 2169 2177 2-s2.0-84882589554 10.1093/bioinformatics/ btt373